AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Verhoeven, GT Wijkhuijs, AJM Hooijkaas, H Hoogsteden, HC Sluiter, W
Citation: Gt. Verhoeven et al., Effect of an inhaled glucocorticoid on reactive oxygen species production by bronchoalveolar lavage cells from smoking COPD patients, MEDIAT INFL, 9(2), 2000, pp. 109-113

Authors: Verhagen, OJHM Willemse, MJ Breunis, WB Wijkhuijs, AJM Jacobs, DCH Joosten, SA van Wering, ER van Dongen, JJM van der Schoot, CE
Citation: Ojhm. Verhagen et al., Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia, LEUKEMIA, 14(8), 2000, pp. 1426-1435

Authors: Verhagen, OJHM Wijkhuijs, AJM van der Sluijs-Gelling, AJ Szczepanski, T van der Linden-Schrever, BEM Pongers-Willemse, MJ van Wering, ER van Dongen, JJM van der Schoot, CE
Citation: Ojhm. Verhagen et al., Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques, LEUKEMIA, 13(8), 1999, pp. 1298-1299

Authors: Szczepanski, T Beishuizen, A Pongers-Willemse, MJ Hahlen, K Van Wering, ER Wijkhuijs, AJM Tibbe, GJM De Bruijn, MAC Van Dongen, JJM
Citation: T. Szczepanski et al., Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease, LEUKEMIA, 13(2), 1999, pp. 196-205

Authors: Szczepanski, T Pongers-Willemse, MJ Langerak, AW Harts, WA Wijkhuijs, AJM van Wering, ER van Dongen, JJM
Citation: T. Szczepanski et al., Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage, BLOOD, 93(12), 1999, pp. 4079-4085

Authors: Pongers-Willemse, MJ Verhagen, OJHM Tibbe, GJM Wijkhuijs, AJM de Haas, V Roovers, E van der Schoot, CE van Dongen, JJM
Citation: Mj. Pongers-willemse et al., Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes, LEUKEMIA, 12(12), 1998, pp. 2006-2014
Risultati: 1-6 |